Economic aspects of vaccination

Vaccine

Volumn 14, Issue 10, 1996, Pages 941-943

  Demicheli, V ^a   Jefferson, T ^a  

^a Institute Medical Statistics   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CHOLERA VACCINE; DIPHTHERIA VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; JAPANESE ENCEPHALITIS VACCINE; MEASLES VACCINE; MENINGOCOCCUS VACCINE; MUMPS VACCINE; PLAGUE VACCINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; RABIES VACCINE; ROTAVIRUS VACCINE; TETANUS TOXOID; TICK BORNE ENCEPHALITIS VACCINE; TYPHOID VACCINE; VARICELLA ZOSTER VACCINE; YELLOW FEVER VACCINE;

ANTIBODY TITER; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; ECONOMIC ASPECT; EDITORIAL; HUMAN; IMMUNOLOGICAL MEMORY; MEDICAL DECISION MAKING; POLICY; PRIORITY JOURNAL; VACCINATION;

EID: 0029782995     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(96)00088-6     Document Type: Editorial

References (12)

1. A. Elixhauser Health care cost-benefit and cost-effectiveness analysis ( CBA CEA ). From 1979 to 1990: a bibliography 8th edn Medical Care 31 1993 1 149 (suppl)
2. T.O. Jefferson V. Demicheli Is vaccination against Hepatitis B efficient? A review of world literature Health Economics 3 1994 25 37
3. J.F. Fries E. Koop C.E. Beadle Reducing health care costs by reducing the need and demand for medical services New England Journal of Medicine 329 1993 321 325
4. J.M. Maucher S.R. Gambert Cost-effective analysis of Influenza vaccination in the elderly Age 13 1990 81 85
5. M.A. Riddiough J.E. Sisk J.C. Bell Influenza vaccination: cost-effectiveness and public policy Journal of the American Medical Association 249 1983 3189 3195
6. Office of Technology Assessment US Congress Cost-effectiveness of Influenza vaccination 1982 Government Printing Office Washington
7. I.L. Thomas Cost-effectiveness of antenatal Hepatitis B screening and vaccination of infants Australia and New Zealand Journal of Obstetrics and Gynaecology 30 1990 331 335
8. B.S. Bloom A.L. Hillman A.M. Fendrick J. Sanford Schwartz A reappraisal of hepatitis B virus vaccination strategies using cost-effectiveness analysis Annals of Internal Medicine 118 1993 298 306
9. M. Krahn A.S. Detsky Should Canada and the United States universally vaccinate infants agaist Hepatitis B? A cost-effectiveness analysis Medical Decision Making 13 1993 4 20
10. G. Tormans P. VanDamme G. Carrin R. Clara W. Eylenbosh Cost-effectiveness analysis of prenatal screening and vaccination against Hepatitis B virus — the case of Belgium Social Science and Medicine 37 1993 173 181
11. T.O. Jefferson R. Behrens V. Demicheli Should British soldiers be vaccinated agaist Hepatitis A? An economic analysis Vaccine 12 1994 1379 1383
12. R. van den Oever D. de Graeve B. Hepp Pharmaeconomics of immunisation. A review Pharma-Economics 3 1993 286 308